Leavell Investment Management’s Kinross Gold KGC Stock Holding History

Leavell Investment Management’s Portfolio KGC Stock Details KGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,468	Closed	-$170K	–	583
2025 Q1	$170K	Buy	+13,468	New	+$151K	0.01%	545

Other funds holding KGC

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Leavell Investment Management's KGC Position: Q2 2025 in Review

Leavell Investment Management sold out of Kinross Gold (KGC) in Q2 2025, closing a stake of 13,468 shares — an estimated $170K sold.

Leavell Investment Management first reported a position in KGC in Q1 2025 and held it in 1 quarter. The position peaked at $170K in Q1 2025. 503 funds tracked by Wall St. Rank hold KGC as of Q2 2025.

Leavell Investment Management reported no remaining Kinross Gold position as of Q2 2025 after selling out during the quarter.
Leavell Investment Management sold 13,468 Kinross Gold shares in Q2 2025, an estimated $170K.
Leavell Investment Management first reported a position in Kinross Gold in Q1 2025 and held it in 1 quarter.
Leavell Investment Management's Kinross Gold position peaked at $170K in Q1 2025.
503 funds tracked by Wall St. Rank held Kinross Gold as of Q2 2025.

Based on Leavell Investment Management's 13F filing for Q2 2025, filed 31 Jul 2025.